Related by context. All words. (Click for frequent words.) 69 Miraxion 68 elotuzumab 68 ocrelizumab 68 custirsen 67 daclizumab 67 Dimebon 67 Phenoptin 66 Dacogen injection 66 Huntexil 66 lumiliximab 66 Amigal 66 interferon gamma 1b 65 ularitide 65 phase IIa clinical 65 phase IIb clinical 65 darapladib 65 Plicera 65 tanespimycin 65 6R BH4 65 Ocrelizumab 65 GAMMAGARD 64 dirucotide 64 alvespimycin 64 GSK# [001] 64 rasagiline tablets 64 JAK inhibitor 64 Bicifadine 64 Nuvion 64 vosaroxin 64 muraglitazar 64 MDV# 64 R#/MEM # 64 atacicept 64 Pimavanserin 64 tasocitinib 64 lacosamide 64 phase IIb 64 Amrubicin 64 Fampridine SR 64 Zerenex 64 celgosivir 64 INCB# [001] 64 axitinib 63 LymphoStat B 63 Riquent 63 PEG PAL 63 Sulonex 63 CIMZIA TM certolizumab pegol 63 ACTEMRA 63 REMICADE ® 63 CDP# 63 KRN# 63 ELND# 63 forodesine 63 phase IIa 63 Serdaxin 63 TYZEKA 63 temsirolimus 63 Archexin 63 Tasimelteon 63 glufosfamide 63 omecamtiv mecarbil 63 vandetanib 63 Fibrillex TM 63 AZILECT R 63 ISIS # 63 methylnaltrexone 63 alvimopan 63 enzastaurin 63 ZYBRESTAT 63 YONDELIS 63 tafamidis 63 albinterferon alfa 2b 63 TELCYTA 63 R#/MEM 63 Targretin 63 HuLuc# 63 AZILECT ® 63 bicifadine 62 NATRECOR R 62 Traficet EN 62 Cimzia ® 62 Rebif ® 62 Phase 2a trial 62 PF # [001] 62 PD LID 62 elagolix 62 certolizumab pegol 62 CIMZIA TM 62 AVONEX ® 62 Asentar 62 Androxal TM 62 Rasagiline 62 ponatinib 62 Phase IIa clinical 62 Mipomersen 62 fostamatinib 62 ICA # 62 tofacitinib 62 Phase Ib 62 Bezielle 62 RG# [001] 62 confirmatory Phase III 62 picoplatin 62 RSD# oral 62 talactoferrin 62 lomitapide 62 KNS # 62 ELACYT 62 Phase IIIb clinical 62 teduglutide 62 EGS# 62 adalimumab 62 Daclizumab 62 aflibercept 62 ACTEMRA TM 62 PEG Interferon lambda 62 glatiramer acetate 62 HGS ETR1 62 abatacept 62 Alzhemed TM 62 RAPTIVA 62 brivaracetam 62 Zalbin 62 vidofludimus 62 Betaferon ® 62 ancrod 62 ataluren 62 Cimzia R 62 tocilizumab 62 PRT# 62 RoACTEMRA 62 otelixizumab 62 BAY #-# 62 Corlux 62 biologic therapy 62 EndoTAG TM -1 62 iniparib 62 rNAPc2 62 regadenoson 62 tramiprosate ALZHEMED TM 62 TELINTRA 62 mapatumumab 62 PRX # 62 teriflunomide 61 baminercept 61 AGILECT R 61 evaluating tivozanib 61 Rasilez Tekturna 61 FTY# 61 INCB# [002] 61 Azixa 61 milnacipran 61 refractory gout 61 L BLP# 61 Phase 2b study 61 mipomersen 61 SILENOR TM 61 febuxostat 61 Vilazodone 61 OHR/AVR# 61 Phase 2b clinical 61 regorafenib 61 GSK# [002] 61 AZD# 61 velafermin 61 Cimzia TM 61 PROMACTA 61 APD# 61 riociguat 61 Lu AA# 61 ATACAND 61 torezolid phosphate 61 dacetuzumab 61 HGS# 61 Torisel 61 blinded randomized placebo controlled 61 DDP# 61 Stedivaze 61 Pegasys ® 61 vilazodone 61 registrational 61 Troxatyl 61 EOquin 61 Neurodex 61 Phase III clinical 61 ruboxistaurin 61 FOLOTYN ® 61 telbivudine 61 Perforomist TM Inhalation Solution 61 cabazitaxel 61 pertuzumab 61 safinamide 61 Actilon 61 XL# [003] 61 eprotirome 61 Bronchitol 61 Phase 2a clinical 61 pomalidomide 61 PXD# 61 SEROQUEL XR 60 betrixaban 60 refractory chronic lymphocytic 60 sunitinib malate 60 NP2 Enkephalin 60 Nexavar ® 60 Unit Dose Budesonide 60 ranolazine 60 Canvaxin 60 sorafenib tablets 60 midstage clinical 60 ofatumumab 60 ezogabine 60 Adalimumab 60 CIMZIA ™ 60 MGCD# [001] 60 Actimmune ® 60 fingolimod 60 FAMPYRA 60 Cetrorelix 60 Panzem R 60 MAP# 60 Azedra 60 senicapoc 60 CoFactor 60 Sprycel dasatinib 60 Insegia 60 fenofibric acid 60 Icatibant 60 cangrelor 60 visilizumab 60 pradefovir 60 Dapagliflozin 60 TBC# 60 pirfenidone 60 Panzem R NCD 60 romidepsin 60 aleglitazar 60 natalizumab 60 Pirfenidone 60 Zelapar 60 Clolar ® 60 SEROQUEL 60 FOLOTYN 60 tamibarotene 60 synthetic retinoid 60 Phase IIa clinical trials 60 Allovectin 7 R 60 Aurexis 60 UVIDEM 60 diabetic neuropathic pain 60 PHX# 60 MYDICAR ® 60 oxypurinol 60 ganetespib 60 oral ridaforolimus 60 NUVIGIL 60 BENLYSTA ® 60 Starlix 60 Cladribine Tablets 60 BCX# 60 cancer cachexia 60 nonclinical studies 60 MAXY G# 60 orBec 60 HuMax CD4 60 Phase IIa trials 60 LY# [003] 60 mixed dyslipidemia 60 dextromethorphan quinidine 60 SILENOR 60 perifosine 60 primary hypercholesterolemia 60 R sorafenib tablets 60 Phase IIb clinical 60 Allovectin 7 60 romiplostim 60 Aflibercept 60 sunitinib 60 TORISEL 60 dirucotide MBP# 60 valopicitabine 60 Allovectin 7 ® 60 ZOLINZA 60 Northera 60 lupus nephritis 60 posaconazole 60 placebo controlled Phase 60 standard chemotherapy regimen 60 evaluating Actimmune 60 opioid induced bowel dysfunction 60 GFT# 60 limiting toxicity 60 Desmoteplase 60 HER2 positive metastatic breast 60 Phase #/#a 60 novel VDA molecule 60 anakinra 59 Exelixis XL# 59 HCD# [002] 59 Phase 1b trial 59 vemurafenib 59 Laquinimod 59 Perforomist ™ Inhalation Solution 59 TACI Ig 59 aclidinium 59 Cloretazine R VNP#M 59 Ostarine 59 ULORIC 59 C1 INH 59 Viprinex 59 maribavir 59 teplizumab 59 Xanafide 59 tezampanel 59 relapsed SCLC 59 PRISTIQ 59 xanthine oxidase inhibitor 59 relapsing remitting multiple sclerosis 59 desvenlafaxine succinate 59 Phase 2a clinical trials 59 lesinurad 59 Tarceva TM 59 AIM HIGH 59 plus COPEGUS 59 Viramidine 59 Cycloset 59 ProSavin 59 lorvotuzumab mertansine 59 tesmilifene 59 GALNS 59 urocortin 2 59 ambrisentan 59 tasimelteon 59 NGX# 59 oral prodrug 59 Catena ® 59 ORENCIA ® 59 Gemzar ® 59 SPRYCEL ® 59 heterozygous FH 59 Phase IIa trial 59 lixivaptan 59 Phenserine 59 Raptiva ® 59 tolvaptan 59 tramiprosate Alzhemed TM 59 pexelizumab 59 AEGR 59 acyclovir Lauriad R 59 IDX# 59 panitumumab Vectibix 59 Urocortin 2 59 saxagliptin 59 LEVADEX ™ 59 dyskinesia PD LID 59 GW# [003] 59 TYKERB 59 COPAXONE R 59 Zolinza 59 RhuDex 59 rilonacept 59 faropenem 59 evaluating REVLIMID 59 PREZISTA r 59 TRIOLEX 59 MAGE A3 ASCI 59 active comparator 59 Promacta 59 Nasulin 59 donepezil 59 CIMZIA 59 efalizumab 59 TRISENOX 59 pegylated interferons 59 RhuDex ® 59 cannabinor 59 PDX pralatrexate 59 PRTX 59 Yervoy 59 SinuNase TM 59 aclidinium bromide 59 ONTAK 59 metformin sulfonylurea 59 protease inhibitor PI 59 paliperidone ER 59 pseudobulbar affect PBA 59 Phase IIb trials 59 lintuzumab 59 Locteron 59 ATryn R 59 COPAXONE ® 59 XL# SAR# 59 Nexavar sorafenib 59 UPLYSO 59 TroVax 59 XL# XL# 59 AVE# 59 Phase 2b clinical trials 59 Phase 1b clinical 59 GATTEX ® 59 AVN# [001] 59 dasatinib Sprycel ® 59 recurrent glioblastoma multiforme 59 Phase Ib study 59 docetaxel Taxotere R 59 MBP# [001] 59 canakinumab 59 ixabepilone 59 iloperidone 59 MACUGEN 59 MAXY alpha 59 compound INCB# 59 QLT# 59 FASLODEX 59 Ixempra 59 belinostat 59 Neupro R 59 #D#C# 59 PDE4 inhibitor 59 phase IIb study 59 ZACTIMA 59 davunetide 59 monotherapy 59 non alcoholic steatohepatitis 59 thymalfasin 59 schizophrenia CIAS 59 chorea associated 59 nalbuphine ER 59 APTIVUS r 59 Clonicel 59 registrational trial 59 bifeprunox 59 ONGLYZA ™ 59 uric acid lowering 59 azacitidine 59 incyclinide 59 lixisenatide 59 Chemophase 59 TOLAMBA 59 SNT MC# 59 Teriflunomide 59 Aryplase 59 sitaxsentan 59 TYGACIL 59 AZILECT 59 ATL# [001] 59 OncoVEX GM CSF 59 Albuferon 59 TOCOSOL Paclitaxel 59 Dalbavancin 59 EFAPROXYN 59 tolevamer 59 HuMax CD# 59 PREOS 59 viral kinetics 59 Tarceva erlotinib 59 BRIM3 59 Tyrima 59 Shigamabs ® 59 phase Ib 59 entinostat 59 oral methylnaltrexone 58 cutaneous T cell 58 INCB# [003] 58 GVAX 58 Phase 2a 58 eniluracil 58 lintuzumab SGN 58 Campath ® 58 solanezumab 58 Telcyta 58 catheter occlusion 58 rindopepimut 58 relapsed multiple myeloma 58 Diamyd ® 58 sapacitabine 58 CYCLOSET 58 ORENCIA R 58 Reverset 58 docetaxel Taxotere ® 58 eltrombopag 58 investigational compound 58 TREDAPTIVE 58 albiglutide 58 eprodisate Fibrillex TM 58 PEG INTRON 58 ridaforolimus 58 lurasidone 58 severe gastroparesis 58 OXi# 58 Pivotal Phase III 58 Phase IIb clinical trials 58 TKM ApoB 58 refractory Hodgkin lymphoma 58 bendamustine 58 Mylotarg 58 ISENTRESS 58 Cinquil 58 PEG SN# 58 JANUVIA 58 REMOXY ® 58 Phase Ib clinical 58 sorafenib 58 IMA# 58 NVA# 58 IMiDs 58 Revlimid lenalidomide 58 rotigotine 58 refractory AML 58 ONGLYZA 58 metastatic hormone refractory 58 LIALDA 58 retigabine 58 Virulizin ® 58 Multiple Ascending Dose 58 ILLUMINATE 58 Zemplar Capsules 58 phase IIb trial 58 infliximab 58 galiximab 58 postoperative ileus POI 58 investigational compounds 58 inhibitor RG# 58 Marqibo 58 Relovair 58 AZOR 58 candesartan cilexetil 58 ecallantide 58 adalimumab Humira 58 Sebivo 58 voreloxin 58 Telintra 58 glucokinase activator 58 afatinib 58 Dasatinib 58 inhaled iloprost 58 dacarbazine 58 ATryn ® 58 sorafenib Nexavar 58 Triolex 58 Empatic 58 dexpramipexole 58 ZETIA 58 Virulizin R 58 HspE7 58 Entereg R 58 candesartan 58 XL# XL# XL# XL# 58 bevirimat 58 mGluR2 NAM 58 PEGylated interferon beta 1a 58 bardoxolone 58 valtorcitabine 58 Syncria 58 aplindore 58 obatoclax 58 alagebrium 58 AGILECT ® 58 TNFerade 58 Clofarabine 58 dosing cohort 58 IRESSA 58 reslizumab 58 AVASTIN 58 Vandetanib 58 Arcalyst 58 VELCADE melphalan 58 ALTACE 58 CTAP# Capsules 58 neratinib 58 migalastat HCl 58 tecarfarin 58 SAPHRIS 58 Atacand 58 Cimzia ® certolizumab pegol 58 Actemra 58 Vitaxin 58 blinatumomab 58 dexanabinol 58 induced macular edema 58 cediranib 58 Phase 1b 58 Oral NKTR 58 Firazyr 58 peg interferon 58 HEPLISAV 58 Fludara 58 cilengitide 58 APTIVUS 58 abatacept Orencia 58 bosentan 58 atorvastatin Lipitor 58 gefitinib Iressa 58 anidulafungin 58 IL# PE#QQR 58 AzaSite Plus 58 imatinib resistant 58 QAB# 58 CANCIDAS 58 LymphoStat B TM 58 Viprinex TM 58 confirmatory Phase 3 58 EDEMA3 58 ALN PCS 58 Pemetrexed 58 CYT# 58 Puricase 58 octreotide 58 generation purine nucleoside 58 erlotinib Tarceva 58 ACE inhibitor ramipril 58 symptomatic neurogenic orthostatic hypotension 58 Ambrisentan 58 ASA# 58 ENBREL 58 LEVADEX TM 58 Rotigotine 58 Targretin capsules 58 LAF# 58 neurogenic orthostatic hypotension 58 fondaparinux 58 severe hypercholesterolemia 58 Zenvia ™ 58 2 methoxyestradiol 58 tremelimumab 58 placebo controlled clinical 58 pharmacokinetic PK study 58 elvucitabine 58 ramelteon 58 ARCALYST 58 CABP 58 Interferon beta 1a 58 FavId 58 Jevtana 58 CRMD# 58 bevacizumab Avastin ® 58 SinuNase 58 metastatic castration resistant 58 Golimumab 58 SCH # 58 BRILINTA 58 Betaferon R 58 CAELYX 58 Potiga 58 phase Ib clinical 58 clinical pharmacology studies 58 decitabine 58 LibiGel ® 58 LymphoStat B belimumab 58 selective modulator 58 pimavanserin 58 INTEGRILIN 58 rFIXFc 58 TNF inhibitor 58 Tanespimycin 58 oral rivaroxaban 58 Cethromycin 58 Trizytek 58 linaclotide 58 Xyrem ® 57 Onalta 57 Synavive 57 etanercept 57 donepezil Aricept 57 NLX P# 57 carfilzomib 57 initiate Phase 1b 57 PEGylated Fab fragment 57 PEG Intron 57 RELOVAIR ™ 57 placebo controlled Phase III 57 ulimorelin 57 IRX 2 57 LEUKINE 57 LibiGel Phase III 57 HQK 57 PS# [001] 57 lapatinib Tykerb 57 subcutaneous formulation 57 tramiprosate 57 Kuvan 57 Navelbine ® 57 chlorambucil 57 Ramelteon 57 Forodesine HCl 57 peginesatide 57 AGGRASTAT ® 57 XL# XL# XL# 57 efficacy endpoints 57 placebo controlled trials 57 entecavir 57 Abilify aripiprazole 57 indacaterol 57 Ophena TM 57 rasagiline 57 Bayer Onyx 57 NUEDEXTA 57 elacytarabine 57 Hyphanox 57 denufosol 57 adecatumumab 57 Onbrez Breezhaler 57 irbesartan 57 Saxagliptin 57 Phase #b/#a trial 57 Symbyax 57 pegloticase 57 Ceflatonin R 57 CYT# QbG# 57 Phase #b/#a 57 efficacy tolerability 57 danoprevir 57 metastatic HRPC 57 metaglidasen 57 relapsing MS 57 Phase IIa 57 HepeX B 57 taliglucerase alfa 57 investigational drug 57 PEGINTRON TM 57 DPX Survivac 57 class mGluR5 inhibitor 57 Exelixis compounds 57 Certolizumab pegol 57 tetrabenazine 57 GOUT 57 antihypertensive agents 57 MAA submission 57 Joulferon 57 ALTU 57 volociximab 57 vernakalant oral 57 CINTREDEKIN BESUDOTOX 57 BMS # 57 desvenlafaxine 57 Phase IIb trial 57 BRIM2 57 Zenvia Phase III 57 PEG interferon 57 AEG# 57 calcineurin inhibitors 57 figitumumab 57 docetaxel chemotherapy 57 interferon beta 1b 57 LUNESTA 57 oral FTY# 57 Glufosfamide 57 tesetaxel 57 hepatitis C HCV 57 BLA submission 57 Zoraxel 57 olmesartan 57 Phase IIB 57 metastatic RCC 57 SNRI 57 squalamine 57 Arranon 57 HuMax EGFr 57 thetreatment 57 REPLAGAL 57 cardio renal 57 pharmacological chaperone 57 Hematide 57 NOXAFIL 57 rolofylline 57 pramlintide 57 arimoclomol 57 Genasense ® 57 non metastatic osteosarcoma 57 paliperidone palmitate 57 Benlysta belimumab 57 APEX PD 57 CRx 57 Gabapentin GR 57 aripiprazole 57 Cerovive 57 phase III isavuconazole 57 Amplimexon 57 Milnacipran 57 terlipressin 57 XL# anticancer compounds 57 IPX# 57 VEGF Trap 57 LEXIVA 57 casopitant 57 Fx #A 57 liprotamase 57 enoximone 57 Vidofludimus 57 pitavastatin 57 Epivir 57 CR# vcMMAE 57 intravenous methylnaltrexone 57 dose escalation phase 57 SARMs 57 TTR amyloidosis 57 Oxypurinol 57 imatinib therapy 57 vicriviroc 57 Æterna Zentaris 57 LATUDA 57 PEGylated anti 57 oxaliplatin Eloxatin 57 AMR# 57 NEBIDO 57 mGluR5 negative 57 AZD# TC 57 low dose cytarabine 57 hormone refractory prostate cancer 57 pharmacodynamic 57 Prestara 57 HUMIRA 57 SIMPONI 57 tezampanel NGX# 57 Aptivus ® 57 lubiprostone 57 bortezomib 57 MPS IVA 57 ALKS 57 phase 2a 57 EOquin TM 57 Phase 1b dose escalation 57 CORLUX 57 clopidogrel Plavix 57 Soliris TM eculizumab 57 PDE# inhibitors 57 MYCAMINE 57 VEGF Trap Eye 57 GLPG# 57 Genz # 57 rFVIIIFc 57 DP b# 57 octreotide acetate 57 ASONEP 57 Onrigin 57 pralatrexate 57 ADAGIO study 57 relapsed refractory multiple myeloma 57 Posiphen 57 Sandostatin LAR 57 EP #R 57 eculizumab 57 Octreotide 57 including eniluracil ADH 57 inhaled liposomal ciprofloxacin 57 Phase IIIb 57 idiopathic pulmonary fibrosis IPF 57 SYMBICORT 57 Taxotere R 57 panitumumab 57 prucalopride 57 Surfaxin LS 57 adipiplon 57 CEQ# 57 dasatinib 57 MERLIN TIMI 57 RRMS patients 57 RLAI 57 gemcitabine Gemzar ® 57 Ceflatonin ® 57 certolizumab 57 RGB # 57 relapsed MM 57 BCR ABL inhibitor 57 Actimmune R 57 esophageal candidiasis 57 oxymorphone ER 57 deforolimus 57 YERVOY 57 pegylated interferon alfa 2a 57 Xinlay 57 eosinophilic asthma 57 taribavirin 57 QNEXA 57 dopamine receptor agonist 57 ARIMIDEX 57 beta 1a 57 Cancidas 57 dalbavancin 57 Tocosol Paclitaxel 57 ceftaroline 57 Azilect ® 57 vernakalant 57 IV APAP 57 HBeAg positive patients 57 FM VP4 57 Celacade TM 57 OvaRex ® MAb 57 IBS C 57 APPRAISE 57 erlotinib Tarceva ® 57 ruxolitinib 57 viral kinetic 57 PANVAC VF 57 Cleviprex TM clevidipine 57 Veronate 57 SPARLON 57 guanfacine extended release 57 alemtuzumab 57 velaglucerase alfa 57 IIa trial 57 RDEA# 57 Phase Ib II 57 HCV SPRINT 57 diabetic nephropathy 57 BARACLUDE ® 57 silodosin 57 Eltrombopag 57 LEVADEX 57 COREG 56 amrubicin 56 Cimzia certolizumab pegol 56 Dextofisopam 56 lymphoma CTCL 56 post herpetic neuralgia PHN 56 Clevudine 56 Naglazyme 56 budiodarone 56 mRCC 56 chemotherapy induced neutropenia 56 Atrasentan 56 pan HDAC inhibitor 56 bosutinib 56 JP-#/fipamezole 56 Intravenous CP 56 LHON 56 atypical antipsychotic medication 56 exenatide 56 ABILIFY 56 pediatric Crohn disease 56 pharmacokinetic PK 56 golimumab 56 AP# [003] 56 TRANSDUR Sufentanil 56 fidaxomicin 56 placebo controlled clinical trials 56 plus prednisone prednisolone 56 cetuximab Erbitux 56 DU #b 56 Vectibix 56 TNF alpha inhibitor 56 Neuradiab 56 peginterferon alpha 2a 56 Balaglitazone 56 Sycrest 56 Frova R 56 ropinirole Requip 56 ARCOXIA 56 phase IIIb 56 Elocalcitol 56 RAPTIVA R 56 tiapamil 56 selective androgen receptor modulator 56 Tasigna nilotinib 56 ciclesonide 56 MEND CABG II 56 MIRAPEX ER 56 #ME# 56 interferon beta 1a 56 novel histone deacetylase 56 GATTEX TM 56 allopurinol 56 COPEGUS 56 pharmacokinetic equivalence 56 Zelrix 56 zalutumumab 56 Phase 2b trial 56 Revimmune 56 Noxafil 56 XmAb# 56 goserelin 56 carcinoid syndrome 56 CA4P 56 Pivotal Phase 56 Ventavis 56 HMG CoA reductase inhibitors 56 Oglemilast 56 methylnaltrexone bromide 56 tolerability profile 56 sargramostim 56 dapagliflozin 56 Cloretazine 56 Xenazine 56 pegylated interferon alpha 56 Phase Ia 56 EMSAM 56 CINQUIL 56 ZADAXIN 56 levodopa 56 FOLFIRI 56 eszopiclone 56 ENRICH trial 56 secondary efficacy endpoints 56 tanezumab 56 Heplisav 56 Tipranavir 56 Quinamed 56 HCV protease inhibitor